Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
James M Brown, D.O.
Family Practice · YUKON, OK · NPI 1063429892
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 294 | 61 |
| Levothyroxine Sodium | Levothyroxine Sodium | 282 | 73 |
| Gabapentin | Gabapentin | 274 | 64 |
| Atorvastatin Calcium | Atorvastatin Calcium | 233 | 69 |
| Omeprazole | Omeprazole | 222 | 57 |
| Tamsulosin Hcl | Tamsulosin Hcl | 219 | 49 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 200 | 47 |
| Trazodone Hcl | Trazodone Hcl | 181 | 42 |
| Lisinopril | Lisinopril | 172 | 48 |
| Metformin Hcl | Metformin Hcl | 164 | 44 |
| Losartan Potassium | Losartan Potassium | 162 | 47 |
| Tramadol Hcl | Tramadol Hcl | 150 | 53 |
| Simvastatin | Simvastatin | 145 | 42 |
| Azithromycin | Azithromycin | 135 | 100 |
| Hydrochlorothiazide | Hydrochlorothiazide | 120 | 35 |
| Tizanidine Hcl | Tizanidine Hcl | 119 | 51 |
| Amlodipine Besylate | Amlodipine Besylate | 107 | 32 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 103 | 24 |
| Alprazolam | Alprazolam | 102 | 24 |
| Duloxetine Hcl | Duloxetine Hcl | 97 | 20 |
| Meloxicam | Meloxicam | 96 | 26 |
| Pantoprazole Sodium | Pantoprazole Sodium | 93 | 28 |
| Cephalexin | Cephalexin | 90 | 62 |
| Glipizide | Glipizide | 89 | 22 |
| Montelukast Sodium | Montelukast Sodium | 89 | 25 |
| Citalopram Hbr | Citalopram Hydrobromide | 88 | 21 |
| Pioglitazone Hcl | Pioglitazone Hcl | 81 | 21 |
| Carvedilol | Carvedilol | 77 | 20 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 72 | 16 |
| Furosemide | Furosemide | 71 | 30 |
| Metoprolol Succinate | Metoprolol Succinate | 70 | 19 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 66 | 36 |
| Ondansetron Odt | Ondansetron | 66 | 26 |
| Metoprolol Tartrate | Metoprolol Tartrate | 65 | 14 |
| Pregabalin | Pregabalin | 63 | 12 |
| Celecoxib | Celecoxib | 60 | 17 |
| Propranolol Hcl | Propranolol Hcl | 60 | 11 |
| Escitalopram Oxalate | Escitalopram Oxalate | 57 | 16 |
| Prednisone | Prednisone | 57 | 49 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 54 | 15 |
| Ozempic | Semaglutide | 54 | suppressed |
| Allopurinol | Allopurinol | 53 | 16 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 53 | 40 |
| Clopidogrel | Clopidogrel Bisulfate | 53 | 16 |
| Potassium Chloride | Potassium Chloride | 53 | 13 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 52 | suppressed |
| Atenolol | Atenolol | 50 | 14 |
| Metformin Hcl Er | Metformin Hcl | 50 | 12 |
| Eliquis | Apixaban | 49 | 13 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 44 | suppressed |
| Gemfibrozil | Gemfibrozil | 43 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 43 | 12 |
| Methylprednisolone | Methylprednisolone | 42 | 35 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 42 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 41 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 40 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 40 | suppressed |
| Mounjaro | Tirzepatide | 40 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 40 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 40 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 39 | suppressed |
| Lorazepam | Lorazepam | 39 | 15 |
| Bupropion Xl | Bupropion Hcl | 38 | suppressed |
| Estradiol | Estradiol | 37 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 37 | 16 |
| Fentanyl | Fentanyl | 36 | suppressed |
| Finasteride | Finasteride | 36 | suppressed |
| Trulicity | Dulaglutide | 36 | suppressed |
| Lovastatin | Lovastatin | 35 | suppressed |
| Primidone | Primidone | 35 | suppressed |
| Olanzapine | Olanzapine | 34 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 33 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 33 | suppressed |
| Clonazepam | Clonazepam | 32 | suppressed |
| Famotidine | Famotidine | 32 | suppressed |
| Levetiracetam | Levetiracetam | 31 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 30 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 30 | 17 |
| Glimepiride | Glimepiride | 29 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 28 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 28 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 27 | suppressed |
| Ibuprofen | Ibuprofen | 27 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 26 | suppressed |
| Temazepam | Temazepam | 26 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 24 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 24 | suppressed |
| Synthroid | Levothyroxine Sodium | 24 | suppressed |
| Ezetimibe | Ezetimibe | 23 | suppressed |
| Fluconazole | Fluconazole | 23 | 14 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 23 | suppressed |
| Jardiance | Empagliflozin | 23 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 22 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 22 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | 15 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 22 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 22 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 21 | suppressed |
| Fenofibrate | Fenofibrate | 21 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Naproxen | Naproxen | 21 | suppressed |
| Glyburide | Glyburide | 20 | suppressed |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 20 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 20 | 13 |
| Aripiprazole | Aripiprazole | 19 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 19 | 13 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 19 | suppressed |
| Testosterone | Testosterone | 19 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 18 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | suppressed |
| Diazepam | Diazepam | 18 | suppressed |
| Levofloxacin | Levofloxacin | 18 | 16 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 18 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 17 | 12 |
| Ibandronate Sodium | Ibandronate Sodium | 17 | suppressed |
| Methocarbamol | Methocarbamol | 17 | suppressed |
| Mirtazapine | Mirtazapine | 17 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 16 | suppressed |
| Memantine Hcl | Memantine Hcl | 16 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 16 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 16 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | 11 |
| Hydrocodone-Ibuprofen | Hydrocodone/Ibuprofen | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 15 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 15 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 15 | suppressed |
| Spironolactone | Spironolactone | 15 | suppressed |
| Sucralfate | Sucralfate | 15 | suppressed |
| Topiramate | Topiramate | 15 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 15 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Norethindrone Acetate | Norethindrone Acetate | 14 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 14 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 14 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 13 | suppressed |
| Enbrel | Etanercept | 13 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 12 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Progesterone | Progesterone, Micronized | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 11 | suppressed |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine Dimesylate | 11 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 11 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error